The Onset of Brain Injury and Neurodegeneration Triggers the Synthesis of Docosanoid Neuroprotective Signaling

@article{Bazan2006TheOO,
  title={The Onset of Brain Injury and Neurodegeneration Triggers the Synthesis of Docosanoid Neuroprotective Signaling},
  author={Nicolas G. Bazan},
  journal={Cellular and Molecular Neurobiology},
  year={2006},
  volume={26},
  pages={899-911}
}
  • N. Bazan
  • Published 1 August 2006
  • Biology, Medicine
  • Cellular and Molecular Neurobiology
Bioactive lipid messengers are formed through phospholipase-mediated cleavage of specific phospholipids from membrane reservoirs. Effectors that activate the synthesis of lipid messengers, include ion channels, neurotransmitters, membrane depolarization, cytokines, and neurotrophic factors. In turn, lipid messengers regulate and interact with multiple pathways, participating in the development, differentiation, function (e.g., long-term potentiation and memory), protection, and repair of cells… Expand
Lipids: An insight into the neurodegenerative disorders
Summary Brain development is a sequential anatomical process characterised by specific well-defined stages of growth and maturation. One of the fundamental and necessary events in the normalExpand
Docosahexaenoic acid modulates inflammatory and antineurogenic functions of activated microglial cells
TLDR
This study identifies new relevant potentially protective and proneurogenic functions of DHA, exerted through the modulation of microglial functions, that could be exploited to sustain or promote neuroregenerative processes in damaged/aged brain. Expand
Role of Lipids in Brain Injury and Diseases.
TLDR
This review attempts to provide an overview of the lipid imbalances associated with neurological disorders and CNS injury and a few provocative thoughts to open new avenues for prevention or treatment options. Expand
Activation and reversal of lipotoxicity in PC12 and rat cortical cells following exposure to palmitic acid
TLDR
Results with NGFDPC12 cells suggest a linkage between induction of ASCOS and the apoptotic process and exhibit a temporal window that is sensitive to DHA and BSA interventions. Expand
Modulating the inflammatory properties of activated microglia with Docosahexaenoic acid and Aspirin
TLDR
The combined ability of Aspirin and DHA to modulate microglial activation was determined in the context of pro-inflammatory cytokines, Nitric Oxide levels, as well as total Glutathione levels, thus leading to protection against neurodegenerative diseases with an inflammatory etiology. Expand
Essential Fatty Acid Metabolism in Metabolic Syndrome and Neurological Disorders
Docosahexaenoic acid (DHA) and arachidonic acid (ARA) are important components of neural membrane phospholipids. They are either obtained from the diet or synthesized from their dietary precursors,Expand
Docosahexaenoic acid promotes oligodendrocyte differentiation via PPAR-γ signalling and prevents tumor necrosis factor-α-dependent maturational arrest.
TLDR
Results indicate that DHA might influence the process of OP maturation through its PPAR-γ agonistic activity and provide novel molecular mechanisms for the action of this dietary fatty acid, further supporting the nutritional intervention in demyelinating diseases such as multiple sclerosis. Expand
Protein kinase inhibitors in traumatic brain injury and repair: New roles of nanomedicine.
TLDR
In this review role of several protein kinase inhibitors on TBI induced oxidative stress, blood-brain barrier breakdown, brain edema formation, and resulting brain pathology is discussed in the light of current literature. Expand
Imaging mass spectrometry reveals loss of polyunsaturated cardiolipins in the cortical contusion, hippocampus, and thalamus after traumatic brain injury
TLDR
It is proposed that the CL loss may constitute an upstream mechanism for CL‐driven signaling in different brain regions as an early response mechanism and may also underlie the bioenergetic changes that occur in hippocampal, cortical, and thalamic mitochondria after TBI. Expand
Apolipoprotein D takes center stage in the stress response of the aging and degenerative brain☆
TLDR
Apolipoprotein D emerges as an evolutionarily conserved anti-stress protein that is induced by oxidative stress and inflammation and may prove to be an effective therapeutic agent against a variety of neuropathologies, and even against aging. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 77 REFERENCES
Synaptic lipid signaling: significance of polyunsaturated fatty acids and platelet-activating factor.
  • N. Bazan
  • Biology, Medicine
  • Journal of lipid research
  • 2003
TLDR
Modulation of postsynaptic membrane excitability and long-term synaptic plasticity by cyclooxygenase-2-generated prostaglandin E2, arachidonoyldiacylcylglycerol, and arachidonic acid-containing endocannabinoids is highlighted. Expand
Prostaglandins and other lipid mediators in Alzheimer's disease.
TLDR
This review addresses some current ideas concerning how brain PLA2 and brain PGs are early and key players in acute neural trauma and in brain-cell damage associated with chronic neurodegenerative diseases such as AD. Expand
Modification of ion homeostasis by lipid peroxidation: roles in neuronal degeneration and adaptive plasticity
  • M. Mattson
  • Medicine, Biology
  • Trends in Neurosciences
  • 1998
TLDR
The modification of processes such as outgrowth of neurites and long-term potentiation of synaptic transmission by agents that suppress or promote MLP suggests roles for subtoxic levels of MLP in neuronal plasticity. Expand
Novel Docosanoids Inhibit Brain Ischemia-Reperfusion-mediated Leukocyte Infiltration and Pro-inflammatory Gene Expression*
TLDR
The view that docosahexaenoate only participates in brain damage is challenged and it is demonstrated that this fatty acid is also the endogenous precursor to a neuroprotective signaling response to ischemia-reperfusion. Expand
Phospholipase A2 in the central nervous system: implications for neurodegenerative diseases.
TLDR
Because many neurodegenerative diseases are associated with increased oxidative and inflammatory responses, an attempt was made to include studies on PLA2 in cerebral ischemia, Alzheimer's disease, and neuronal injury due to excitotoxic agents. Expand
Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress.
TLDR
NPD1 protected RPE cells from oxidative-stress-induced apoptosis, and it is predicted that it will similarly protect neurons, and this lipid mediator therefore may indirectly contribute to photoreceptor cell survival as well. Expand
Neuroinflammation, COX-2, and ALS—a dual role?
TLDR
The pathways of COX activity and prostaglandin production form the center of the debate regarding the dual nature of neuroinflammation and how this duality may affect future treatments for neurodegenerative diseases such as ALS is discussed. Expand
Inflammatory Mediators and Stroke: New Opportunities for Novel Therapeutics
  • F. Barone, G. Feuerstein
  • Medicine
  • Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism
  • 1999
TLDR
The realization that brain ischemia and trauma elicit robust inflammation in the brain provides fertile ground for discovery of novel therapeutic agents for stroke and neurotrauma and inhibition of the mitogen-activated protein kinase (MAPK) cascade via cytokine suppressive anti-inflammatory drugs are most promising new opportunities. Expand
Apoptotic and Anti‐Apoptotic Synaptic Signaling Mechanisms
TLDR
The emerging data suggest that synapses can be considered as autonomous compartments in which both pro‐ and anti‐apoptotic signaling pathways are activated resulting in structural and functional changes in neuronal circuits. Expand
Cyclooxygenase‐2 (COX‐2) in Inflammatory and Degenerative Brain Diseases
  • L. Minghetti
  • Medicine
  • Journal of neuropathology and experimental neurology
  • 2004
TLDR
New data is reviewed on some major human neurological diseases, focusing on multiple sclerosis, amyotrophic lateral sclerosis, Parkinson disease, Creutzfeldt-Jakob disease, and Alzheimer disease, where the emerging role of COX-2 in behavioral and cognitive functions will be discussed. Expand
...
1
2
3
4
5
...